封面
市场调查报告书
商品编码
1616702

适应原市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Adaptogens Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 205 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,全球适应原市场价值为107.1 亿美元,预计2024 年至2032 年复合年增长率为6.8%。的兴趣,特别是那些缓解压力并提高能量水平。随着越来越多的人追求整体健康方法,适应原将成为首选。创新新创企业的涌入市场也对其发展发挥重要作用。适应原是帮助身体适应压力源并提高恢復能力的天然物质。

它们在各种产品形式中都很受欢迎,包括补充剂、茶和零食。这种不断增长的需求与预防性健康措施的更广泛趋势以及对天然成分的渴望相一致,进一步推动了市场扩张。适应原作为健康习惯的重要组成部分越来越受到关注,特别是当消费者优先考虑心理健康和福祉时。该市场预计将大幅增长,特别是由于对有助于压力管理、头脑清醒和整体健康的天然产品的需求不断增加。

随着消费者偏好转向整体健康解决方案,将适应原纳入日常生活变得越来越普遍。生产能力和零售店的扩张也促进了行业成长,提高了适应原产品对更广泛受众的可用性。阿什瓦甘达细分市场已成为适应原市场的关键参与者,由于其众所周知的缓解压力和增强能量的特性而受到巨大的需求。人们对阿育吠陀医学和整体健康实践日益增长的兴趣进一步提高了其受欢迎程度,巩固了其作为市场成长主要驱动力的地位。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 107.1 亿美元
预测值 194.5 亿美元
复合年增长率 6.8%

预计到 2032 年,食品和饮料领域的复合年增长率将超过 6.5%。消费者越来越多地在花草茶、能量棒和旨在缓解压力和保持头脑清醒的饮料等产品中寻求天然成分。药局通路在适应原市场中占了很大份额,预计复合年增长率也将超过 6.5%。随着越来越多的消费者转向非处方保健产品,药局正在成为适应原补充品的主要零售店。亚太地区在适应原市场中累积了显着的份额,预计2024 年至2032 年复合年增长率将超过6.5% 这种增长是由印度和中国等国家丰富的传统医学历史推动的,在这些国家,适应原草药一直在使用。随着电子商务平台的兴起,消费者对适应原益处的认识不断提高,这些产品变得更容易获得,并有助于积极的市场前景。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
    • 价值链
    • 主要製造商
    • 前往市场路线
    • 主要经销商
      • 新的分销管道
    • 全行业利润率
  • 产业影响力
    • 成长动力
    • 市场挑战
    • 市场机会
      • 新市场/新应用
      • 成长潜力分析
  • 原料景观
    • 製造趋势
      • 技术演进
    • 各地区定价趋势(美元/吨)
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和亚洲
  • 法规和市场影响
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场规模与预测:按来源划分,2021-2032 年

  • 主要趋势
  • 阿什瓦甘达
  • 黄耆
  • 圣罗勒
  • 红景天
  • 五味子
  • 适应性蘑菇
  • 其他的

第 6 章:市场规模与预测:依最终用途分类,2021-2032 年

  • 主要趋势
  • 粉末
  • 胶囊
  • 茶和饮料
  • 其他的

第 7 章:市场规模与预测:按应用划分,2021-2032 年

  • 主要趋势
  • 食品和饮料来源
  • 膳食和运动补充剂
  • 製药
  • 化妆品
  • 动物饲料

第 8 章:市场规模与预测:按配销通路划分,2021-2032 年

  • 主要趋势
  • 离线
    • 超市/大卖场
    • 药局
    • 杂货店和便利商店
  • 在线的

第 9 章:市场规模与预测:按地区划分,2021-2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • MEA
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • MEA 的其余部分

第 10 章:公司简介

  • REBBL
  • Organic India
  • NutraScience Labs
  • Nutracap Labs
  • Organika Health Products Inc
  • PLT Health Solutions
  • Xi'an Greena Biotech Co. Ltd.
  • Organic Herb Inc
  • Xian Yuensun Biological Technology Co. Ltd.
  • UNO VETCHEM
简介目录
Product Code: 5189

The Global Adaptogens Market was valued at USD 10.71 billion in 2023 and is projected to grow at a CAGR of 6.8% from 2024 to 2032. This impressive growth is largely driven by increasing consumer awareness and a growing interest in natural health remedies, particularly those that relieve stress and boost energy levels. As more individuals pursue holistic approaches to health and wellness, adaptogens will emerge as a preferred choice. The influx of innovative start-ups in the market is also playing a significant role in its development. Adaptogens are natural substances that help the body adapt to stressors and promote resilience.

Their popularity is evident across various product forms, including supplements, teas, and snacks. This rising demand aligns with a broader trend toward preventive health measures and the desire for natural ingredients, further fueling market expansion. Adaptogens are gaining traction as essential components of wellness routines, particularly as consumers prioritize mental health and well-being. The market is set for substantial growth, particularly due to the increasing demand for natural products that aid in stress management, mental clarity, and overall wellness.

As consumer preferences shift towards holistic health solutions, the incorporation of adaptogens into daily routines is becoming more common. The expansion of production capabilities and retail outlets is also bolstering industry growth, enhancing the availability of adaptogen products to a broader audience. The ashwagandha segment has emerged as a key player in the adaptogens market, experiencing significant demand due to its well-known stress-relieving and energy-boosting properties. Its popularity is further enhanced by the growing interest in Ayurvedic medicine and holistic health practices, solidifying its position as a primary driver of market growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$10.71 Billion
Forecast Value$19.45 Billion
CAGR6.8%

The food and beverage segment is expected to register a robust CAGR of over 6.5% through 2032. The rising trend of functional foods and drinks that offer added health benefits is driving this growth. Consumers increasingly seek natural ingredients in products like herbal teas, energy bars, and beverages designed for stress relief and mental clarity. The drug store channel has accounted for a significant share of the adaptogens market, also projected to grow at over 6.5% CAGR. As more consumers turn to over-the-counter health products, drug stores are becoming key retail outlets for adaptogen supplements.The convenience and trust associated with these retailers are pivotal in driving this segment's growth. The Asia Pacific region accumulates a noteworthy share of the adaptogens market and is expected to grow at over 6.5% CAGR from 2024 to 2032. This growth is fueled by a rich history of traditional medicine in countries like India and China, where adaptogenic herbs have been utilized for centuries. Increasing consumer awareness of the benefits of adaptogens, along with the rise of e-commerce platforms, is making these products more accessible and contributing to a positive market outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Data Mining Sources
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Value chain
    • 3.1.2 Key manufacturers
    • 3.1.3 Go to market routes
    • 3.1.4 Key distributors
      • 3.1.4.1 New distribution channels
    • 3.1.5 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Market challenges
    • 3.2.3 Market opportunities
      • 3.2.3.1 New markets/applications
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
      • 3.3.1.1 Technology evolution
    • 3.3.2 Pricing trend, by Region (USD/Ton)
      • 3.3.2.1 North America
      • 3.3.2.2 Europe
      • 3.3.2.3 Asia Pacific
      • 3.3.2.4 Latin America
      • 3.3.2.5 Middle East & Asia
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Ashwagandha
  • 5.3 Ginseng
  • 5.4 Astragalus
  • 5.5 Holy Basil
  • 5.6 Rhodiola Rosea
  • 5.7 Schisandra
  • 5.8 Adaptogenic mushrooms
  • 5.9 Others

Chapter 6 Market Size and Forecast, By End-use, 2021-2032 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Powder
  • 6.3 Capsules
  • 6.4 Teas & beverages
  • 6.5 Others

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Food & Beverage Sources
  • 7.3 Dietary & sports supplements
  • 7.4 Pharmaceutical
  • 7.5 Cosmetics
  • 7.6 Animal Feed

Chapter 8 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 Offline
    • 8.2.1 Supermarket/Hypermarket
    • 8.2.2 Drugstore
    • 8.2.3 Grocery & Convenience Store
  • 8.3 Online

Chapter 9 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 Australia
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 South Africa
    • 9.6.4 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 REBBL
  • 10.2 Organic India
  • 10.3 NutraScience Labs
  • 10.4 Nutracap Labs
  • 10.5 Organika Health Products Inc
  • 10.6 PLT Health Solutions
  • 10.7 Xi'an Greena Biotech Co. Ltd.
  • 10.8 Organic Herb Inc
  • 10.9 Xian Yuensun Biological Technology Co. Ltd.
  • 10.10 UNO VETCHEM